Report Overview
Mycoplasmas Testing Market are a type of bacteria that lack a cell wall. They are commonly found in various environments and can infect cell cultures, particularly in research and manufacturing settings. Contamination of cell cultures by mycoplasma can lead to inaccurate experimental results and compromised production processes, making mycoplasma testing essential. The growth of these industries, along with the increasing use of cell cultures in research, development, and manufacturing processes, has driven the demand for accurate mycoplasma testing.
In 2022, the Global Mycoplasma Testing market was valued at US$ 766.63 million and expected to grow US$ 2338 million in 2032. Between 2023 and 2032, this market is estimated to register a CAGR of 12.11%.
For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2032 – Please check this report :https://market.us/report/mycoplasma-testing-market/
Key Takeaway
Cost Implications False
Positives and Negatives
Diverse Mycoplasma Strains
Test Standardization
Regulatory Compliance
Technological Advancements
Market Key Players
- Agilent Technologies
- American Type Culture Collection
- Asahi Kasei Medical Co. Ltd.
- Biological Industries
- Bionique Testing Laboratories Inc.
- Biotools B M Labs.
- Charles River Laboratories International Inc.,
- Clongen Laboratories Inc
- Creative Bioarray
- Eurofins Scientific
- GenBio,GeneCopoeia Inc
- Lonza Group Ltd.
- Merck KGaA
- Meridian Bioscience Inc.
- Minerva Biolabs GmbH
- Mycoplasma Experience
- Nelson Laboratories Fairfield Inc.
- NorgenBiotek Corp.
- Promo Cell GmbH
- Roche Diagnostic
- Sartorius AG
- Savy on Diagnostics
- Science Cell Research Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Other Key Players
Market Top Segmentations:
Based On Products
- Instruments
- Kits Reagents
- Services
Based On Technique
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- Microbial Culture Techniques
- Enzymatic Methods
- DNA Staining
Based On Testing Type
- By Testing Type
- Cell Line Testing
- Virus Testing
- End of Production Cells Testing
- Others
Based On End User
- Academic Research Institutes
- Cell Banks
- Contract Research Organizations
- Pharmaceutical Biotechnology Companies
- Hospitals and surgical centers
- Clinics
- Community Healthcare
- Others
Market Regional Analysis
-North America [United States, Canada, Mexico]
-South America [Brazil, Argentina, Columbia, Chile, Peru]
-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
-Middle East Africa [GCC, North Africa, South Africa]
-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
Make an inquiry before picking up this report @https://market.us/report/mycoplasma-testing-market/#inquiry
Market Challenges:
Cost Implications
False Positives and Negatives
Diverse Mycoplasma Strains
Test Standardization:
Regulatory Compliance
Contact :
Global Business Development Team – Market.us
Market.us (Powered by Prudour Pvt. Ltd.)
Send Email: inquiry@market.us
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Tel: +1 718 618 4351
Website: https://market.us
